whitepaper

White Paper | ACOG – Screening for Chromosomal Abnormalities

Home » whitepaper Screening for Fetal Chromosomal Abnormalities Prenatal testing for chromosomal abnormalities is designed to provide an accurate assessment of a patient’s risk of carrying a fetus with a chromosomal disorder. A wide variety of prenatal screening and diagnostic tests are available; each offers varying levels of information and performance, and each has relative …

White Paper | ACOG – Screening for Chromosomal Abnormalities Read More »

White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS)

Home » whitepaper Considerations When Ordering Non-invasive Prenatal Screening (NIPS) NIPS generally relies on blood testing from the mother to reveal information from circulating cell-free DNA (cfDNA) from the placenta, which can be identified in the maternal plasma from five weeks after conception. CfDNA is released into the blood stream as small DNA fragments of …

White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS) Read More »